<code id='F758455A3C'></code><style id='F758455A3C'></style>
    • <acronym id='F758455A3C'></acronym>
      <center id='F758455A3C'><center id='F758455A3C'><tfoot id='F758455A3C'></tfoot></center><abbr id='F758455A3C'><dir id='F758455A3C'><tfoot id='F758455A3C'></tfoot><noframes id='F758455A3C'>

    • <optgroup id='F758455A3C'><strike id='F758455A3C'><sup id='F758455A3C'></sup></strike><code id='F758455A3C'></code></optgroup>
        1. <b id='F758455A3C'><label id='F758455A3C'><select id='F758455A3C'><dt id='F758455A3C'><span id='F758455A3C'></span></dt></select></label></b><u id='F758455A3C'></u>
          <i id='F758455A3C'><strike id='F758455A3C'><tt id='F758455A3C'><pre id='F758455A3C'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:7815

          Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

          advertisement

          For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          comprehensive

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Wearables generate powerful data but its not useful to doctors, yet
          Wearables generate powerful data but its not useful to doctors, yet

          AndreaCoravos,managingdirectoratICON,speaksattheSTATBreakthroughSummitWestinSanFranciscoThursdayasId

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Glen Campbell's doctor discusses his public struggle with Alzheimer's

          GlenCampbellperformsinIndio,Calif.,in2008.MichaelBuckner/GettyImagesGlenCampbell’sdecades-longmusica